Edwards Lifesciences (EW) Restructuring Costs (2009 - 2026)

Edwards Lifesciences has reported Restructuring Costs for 18 years, with the latest figure at $6.3 million in Q2 2026.

• On a quarterly basis, Restructuring Costs fell 59.35% year-over-year to $6.3 million in Q2 2026; TTM through Jun 2026 was $342.4 million, a 412.57% increase from a year earlier, with the FY2025 full-year figure at $325.4 million, up 705.45% from the prior year.
• Restructuring Costs was $6.3 million for Q2 2026 at Edwards Lifesciences, down from $37.1 million in the prior quarter.
• The five-year high for Restructuring Costs was $208.6 million in Q4 2025, with the low at -$6.1 million in Q4 2022.
• Average Restructuring Costs over 5 years is $39.1 million, with a median of $10.4 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Restructuring Costs sank 96.71% in 2023, then surged 2681.33% in 2025.
• Over 5 years, Restructuring Costs stood at -$6.1 million in 2022, then soared by 262.3% to $9.9 million in 2023, then dropped by 24.24% to $7.5 million in 2024, then soared by 2681.33% to $208.6 million in 2025, then sank by 96.98% to $6.3 million in 2026.
• The last three Restructuring Costs figures came in at $6.3 million (Q2 2026), $37.1 million (Q1 2026), and $208.6 million (Q4 2025), per Business Quant data.